HC Wainwright Issues Optimistic Estimate for KYMR Earnings
Kymera Therapeutics, Inc. (NASDAQ:KYMR – Free Report) – Equities researchers at HC Wainwright increased their Q2 2025 earnings per share estimates for Kymera Therapeutics in a research report issued on Monday, May 12th. HC Wainwright analyst A. Fein now anticipates that the company will post earnings of ($0.77) per share for the quarter, up from […]
Kymera Therapeutics, Inc. (NASDAQ:KYMR – Free Report) – Equities researchers at HC Wainwright increased their Q2 2025 earnings per share estimates for Kymera Therapeutics in a research report issued on Monday, May 12th. HC Wainwright analyst A. Fein now anticipates that the company will post earnings of ($0.77) per share for the quarter, up from […]
